MONTREAL (AP) _ Theratechnologies Inc. (THTX) on Thursday reported a loss of $22.7 million in its fiscal second quarter.

On a per-share basis, the Montreal-based company said it had a loss of 24 cents.

The metabolic disorder drug company posted revenue of $19.3 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on THTX at https://www.zacks.com/ap/THTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News